FDA Approves Expanded Indication for Two Transcatheter Heart Valves

News The U.S. Food and Drug Administration approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart valves for patients with aortic valve stenosis who are at intermediate risk for death or complications associated with open-heart surgery. Contributed Author:  U.S. Food and Drug Administration Topics:  Cardiovascular